Shares of Stoke Therapeutics sank Tuesday as the drugmaker said its CEO Dr. Edward Kaye is stepping down from his role.

The administration’s bombing campaign against the Iran-backed group is running up against America's political and industrial ...

Ed Kaye, Stoke’s longtime leader, will be replaced by former Vertex executive Ian Smith. Elsewhere, all 12 drugmakers ...

Stoke Therapeutics' chief executive, Edward Kaye, is stepping down after more than seven years at the helm of the biotechnology company. Stoke on Tuesday said Ian Smith, a board member since September ...

BEDFORD, Mass. - Stoke Therapeutics, Inc. (NASDAQ: STOK) shares dropped 4.1% after the biotechnology company announced its CEO Edward M. Kaye will step down, overshadowing better-than-expected fourth ...

Plans have been approved to knock down a "rundown" former Stoke-on-Trent school and youth centre plagued by "ongoing ...

A teacher's battle with skin cancer inspired her students to raise funds for a hospital charity. Pupils from Orme Academy in ...

City’s U18s came from behind to earn our 16th successive league win in a gripping 2-1 victory over Stoke City.Floyd Samba ...

The response has been so strong that Ms Poole and Ms Wood are now on the lookout for a bigger premises – and have applied to ...

George Weaver joins BBC Radio Stoke's Lucas Yeomans to discuss the Potters' last-gasp defeat by Millwall at The Den.